Emtriva (Emtricitabine, FTC)

The Latest

An Overview of Emtriva (Emtricitabine)

Brand Name: Emtriva Other Name(s): FTC Drug Class: Nucleoside Reverse Transcriptase Inhibitors

By AIDSinfo

Emtricitabine (Emtriva)

What Is Emtricitabine? Who Should Take Emtricitabine? What About Drug Resistance? How Is Emtricitabine Taken? What Are the Side Effects? How Does Emtricitabine React With Other Drugs?

What Is Emtricitabine?

Emtricitabine (Emtriva) is a ...

By AIDS InfoNet


Brand name: Emtriva

Generic name: emtricitabine, or FTC

Class: Nucleoside reverse transcriptase inhibitor (nucleoside, NRTI, or nuke)

Manufacturer: Gilead Sciences, Inc., www.gilead.com, (800) GILEAD-5 (445-3235)

AWP: $504.37/month for 200 mg cap...

By Positively Aware

Emtriva (Emtricitabine)

Emtriva capsules are half light blue and half white. The light-blue half shows the dose (200 mg) and the white half says "Gilead" with the Gilead corporate logo on the left. There is also an oral solution available for Emtriva.

Background and Descri...

By The Center for AIDS Information & Advocacy

FTC (Emtriva) Approved

The U.S. FDA announced the approval of FTC (brand name EmtrivaTM, generic name emtricitabine, former brand name CoviracilTM) on July 2, 2003.

FTC is chemically related to 3TC. It was approved primarily on the basis of two clinical trials: one compar...

By John S. James for AIDS Treatment News

U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir

Gilead Sciences received approval from the US Food and Drug Administration Wednesday for a new once-a-day AIDS drug, Emtriva. Known generically as emtricitabine, Emtriva is a nucleoside reverse transcriptase inhibitor. Gilead now hopes to combine Emt...

By CDC National Prevention Information Network